ITMI20051999A1 - Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' - Google Patents

Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'

Info

Publication number
ITMI20051999A1
ITMI20051999A1 ITMI20051999A ITMI20051999A1 IT MI20051999 A1 ITMI20051999 A1 IT MI20051999A1 IT MI20051999 A ITMI20051999 A IT MI20051999A IT MI20051999 A1 ITMI20051999 A1 IT MI20051999A1
Authority
IT
Italy
Prior art keywords
erogability
respirability
nebulizer
drugs
administration
Prior art date
Application number
Other languages
English (en)
Italian (it)
Inventor
Giovanni Caponetti
Loretta Maggi
Cristina Veneziani
Laura Zanellotti
Original Assignee
Eratech S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37806135&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20051999(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eratech S R L filed Critical Eratech S R L
Priority to ITMI20051999 priority Critical patent/ITMI20051999A1/it
Priority to DK06807435.0T priority patent/DK1937229T3/da
Priority to PT68074350T priority patent/PT1937229E/pt
Priority to SI200631930T priority patent/SI1937229T1/sl
Priority to ES06807435.0T priority patent/ES2537777T3/es
Priority to HUE06807435A priority patent/HUE026045T2/hu
Priority to JP2008536060A priority patent/JP5873616B2/ja
Priority to US12/090,899 priority patent/US9138407B2/en
Priority to PCT/EP2006/067619 priority patent/WO2007045689A2/en
Priority to EP06807435.0A priority patent/EP1937229B1/en
Priority to PL06807435T priority patent/PL1937229T3/pl
Priority to RU2008120018/15A priority patent/RU2497507C2/ru
Publication of ITMI20051999A1 publication Critical patent/ITMI20051999A1/it
Priority to CY20151100506T priority patent/CY1116503T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITMI20051999 2005-10-21 2005-10-21 Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' ITMI20051999A1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
ITMI20051999 ITMI20051999A1 (it) 2005-10-21 2005-10-21 Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
RU2008120018/15A RU2497507C2 (ru) 2005-10-21 2006-10-20 Ингаляционные фармацевтические композиции в форме сухих порошков, растворов или суспензий, полученных из них, и способ их получения
JP2008536060A JP5873616B2 (ja) 2005-10-21 2006-10-20 乾燥粉末、またはそれから得られた溶液もしくは懸濁液の形態にある吸入用医薬組成物およびその製造方法
PT68074350T PT1937229E (pt) 2005-10-21 2006-10-20 Composições farmacêuticas inalatórias sob a forma de pós secos, soluções ou suspensões
SI200631930T SI1937229T1 (sl) 2005-10-21 2006-10-20 Farmacevtski sestavki za inhaliranje v obliki suhih praškov, raztopin ali suspenzij
ES06807435.0T ES2537777T3 (es) 2005-10-21 2006-10-20 Composiciones farmacéuticas para inhalación en forma de polvos secos, soluciones o suspensiones
HUE06807435A HUE026045T2 (hu) 2005-10-21 2006-10-20 Inhalálásra alkalmas gyógyszerkészítmények száraz porok, oldatok vagy szuszpenziók formájában
DK06807435.0T DK1937229T3 (da) 2005-10-21 2006-10-20 Farmaceutiske inhalationssammensætninger i form af tørpulvere, opløsninger eller suspensioner
US12/090,899 US9138407B2 (en) 2005-10-21 2006-10-20 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions obtained from the same and process for their preparation
PCT/EP2006/067619 WO2007045689A2 (en) 2005-10-21 2006-10-20 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions
EP06807435.0A EP1937229B1 (en) 2005-10-21 2006-10-20 Inhalatory pharmaceutical compositions in form of dry powders, solutions or suspensions
PL06807435T PL1937229T3 (pl) 2005-10-21 2006-10-20 Wziewne kompozycje farmaceutyczne w postaci suchych proszków, roztworów lub zawiesin
CY20151100506T CY1116503T1 (el) 2005-10-21 2015-06-10 Φαρμακευτικες συνθεσεις για εισπνοη υπο μορφη ξηρης σκονης, διαλυματων ή εναιωρηματων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20051999 ITMI20051999A1 (it) 2005-10-21 2005-10-21 Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'

Publications (1)

Publication Number Publication Date
ITMI20051999A1 true ITMI20051999A1 (it) 2007-04-22

Family

ID=37806135

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI20051999 ITMI20051999A1 (it) 2005-10-21 2005-10-21 Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'

Country Status (13)

Country Link
US (1) US9138407B2 (https=)
EP (1) EP1937229B1 (https=)
JP (1) JP5873616B2 (https=)
CY (1) CY1116503T1 (https=)
DK (1) DK1937229T3 (https=)
ES (1) ES2537777T3 (https=)
HU (1) HUE026045T2 (https=)
IT (1) ITMI20051999A1 (https=)
PL (1) PL1937229T3 (https=)
PT (1) PT1937229E (https=)
RU (1) RU2497507C2 (https=)
SI (1) SI1937229T1 (https=)
WO (1) WO2007045689A2 (https=)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
AU2006335994A1 (en) 2006-01-19 2007-07-26 Optinose As Nasal administration
IN2015DN00888A (https=) 2006-02-22 2015-07-10 Mannkind Corp
US8614236B2 (en) * 2006-12-12 2013-12-24 University Of Washington Methods of treating pulmonary disease using acetazolamide and structurally related derivatives
GB2448183A (en) * 2007-04-05 2008-10-08 Optinose As Nasal powder delivery device
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US8865692B2 (en) * 2007-11-13 2014-10-21 Meritage Pharma, Inc Compositions for the treatment of gastrointestinal inflammation
US20090149433A1 (en) 2007-11-13 2009-06-11 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
EP2534957B1 (en) 2007-12-14 2015-05-27 AeroDesigns, Inc Delivering aerosolizable products
JP5485879B2 (ja) * 2008-05-15 2014-05-07 株式会社ココカラファインネクスト 異なる物性の薬物の一剤形化
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
EP3552602B1 (en) * 2009-03-18 2025-03-05 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
RU2445119C2 (ru) * 2010-05-25 2012-03-20 Сергей Викторович Чепур Фармацевтическая композиция и способ ее ингаляционного введения
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
BR112013007304B1 (pt) * 2010-09-29 2021-12-14 Pulmatrix, Inc. Pós secos de cátion de metal monovalente para inalação
GB2488992A (en) * 2011-03-10 2012-09-19 Advanced Ophthalmic Pharma Ltd Medicament dispenser
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
ES2612257T3 (es) * 2011-05-03 2017-05-16 Chiesi Farmaceutici S.P.A. Formulación de suspensión mejorada de dipropionato de beclometasona para administración mediante inhalación
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
JP6197515B2 (ja) * 2012-10-19 2017-09-20 大正製薬株式会社 医薬組成物
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US10441536B2 (en) * 2013-03-13 2019-10-15 Actavis Group Ptc Ehf Micronized colistimethane sodium pharmaceutical compositions
US9452139B2 (en) 2013-03-14 2016-09-27 Novartis Ag Respirable agglomerates of porous carrier particles and micronized drug
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US11554229B2 (en) 2013-03-26 2023-01-17 OptiNose Inc. Nasal administration
ITMI20130572A1 (it) * 2013-04-10 2014-10-11 Eratech Srl Composizione comprendente almeno due polveri secche ottenute per spray dry per aumentare la stabilita' della formulazione
ITMI20130571A1 (it) * 2013-04-10 2014-10-11 Zambon Spa Composizione farmaceutica contenente budesonide e formoterolo
AU2013388034B2 (en) 2013-04-30 2019-08-15 Aspeya US Inc. Dry powder formulations and methods of use
WO2016004409A1 (en) * 2014-07-03 2016-01-07 Luxena Pharmaceuticals, Inc. Novel aerosol formulations of ondansetron and uses thereof
CN104274426A (zh) 2013-07-03 2015-01-14 陆克塞纳医药公司 昂丹司琼细粉、昂丹司琼气溶胶组合物及其用途
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
RU2539374C1 (ru) * 2013-11-29 2015-01-20 Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) Высокодисперсная комбинированная фармацевтическая композиция беклометазона и сальбутамола с бета-глицином и способ ее получения
GB201321712D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
CN112656780A (zh) 2014-02-20 2021-04-16 奥迪托皮克股份有限公司 用于吸入的干粉制剂
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015187356A1 (en) * 2014-06-04 2015-12-10 Quick Joshua Ryan System and method for delivering an inhalable sugar formulation
MY196072A (en) 2014-09-15 2023-03-13 Verona Pharma Plc Liquid Inhalation Formulation Comprising RPL554
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP6684275B2 (ja) * 2014-10-08 2020-04-22 ザンボン ソシエタ ペル アチオニ ブデソニド及びホルモテロールを含有する医薬組成物
WO2016055544A1 (en) * 2014-10-08 2016-04-14 Eratech S.R.L. Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
MX392636B (es) 2014-10-31 2025-03-24 Glaxosmithkline Ip Dev Ltd Formulacion en polvo.
KR20180030399A (ko) * 2015-08-05 2018-03-22 다이이찌 산쿄 가부시키가이샤 네뷸라이저용 조성물
KR20180050320A (ko) * 2015-09-09 2018-05-14 노파르티스 아게 분무-건조된 제제의 폐로의 표적화된 전달
JP7409772B2 (ja) * 2015-10-20 2024-01-09 スぺファーム アクチェンゲゼルシャフト ダントロレンを含む水性組成物
CN109069495A (zh) 2016-02-01 2018-12-21 英凯达治疗公司 电子监测联合吸入药理学疗法管理包括心房颤动在内的心律失常
ES3055891T3 (en) * 2016-06-30 2026-02-16 Philip Morris Products Sa Nicotine particles and compositions
PL3478265T3 (pl) * 2016-06-30 2025-04-14 Philip Morris Products S.A. Cząstki nikotyny
IL265913B2 (en) 2016-10-14 2024-07-01 Pulmatrix Operating Co Inc Respirable Dry Powder Comprising Itraconazole In Crystalline Form And Its Use For Manufacturing A Medicament For Treating Fungal Infection
KR20190126772A (ko) * 2017-03-07 2019-11-12 필립모리스 프로덕츠 에스.에이. 흡입 가능한 니코틴 제형, 및 이의 제조 및 사용 방법
AU2018266199A1 (en) 2017-05-10 2019-11-07 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
US11344562B2 (en) 2017-08-15 2022-05-31 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation
JP7493449B2 (ja) 2017-09-22 2024-05-31 ヴェクチュラ インコーポレイテッド ステアリン酸マグネシウムを含む乾燥粉末組成物
BR112020013750A8 (pt) 2018-01-05 2022-10-18 Impel Neuropharma Inc Dispensação intranasal de olanzapina por dispositivo olfativo de precisão
US10744087B2 (en) 2018-03-22 2020-08-18 Incarda Therapeutics, Inc. Method to slow ventricular rate
WO2020150460A1 (en) * 2019-01-18 2020-07-23 Milne Iii Donald A Micronized aspirin formulation
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
AU2020323594B2 (en) 2019-08-01 2022-02-03 Incarda Therapeutics, Inc. Antiarrhythmic formulation
RU2730488C1 (ru) * 2019-08-20 2020-08-24 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича" (ИБМХ) Фармацевтическая композиция на основе глюкокортикостероида будесонида и фосфатидилхолина для сухой ингаляции
GB201914532D0 (en) * 2019-10-08 2019-11-20 Univ Of Huddersfield Lactose particles and method of production thereof
RU2735502C1 (ru) * 2020-01-09 2020-11-03 Федеральное государственное бюджетное учреждение науки Удмуртский федеральный исследовательский центр Уральского отделения Российской академии наук Аэрозоль для ингаляций при обструктивном бронхите
CN111202723A (zh) * 2020-02-15 2020-05-29 江苏艾立康药业股份有限公司 一种达芦那韦吸入干粉药物组合物及其制备方法
US20230270754A1 (en) * 2020-07-31 2023-08-31 Chemo Research, S.L. Combination therapy for inhalation administration
US20250108068A1 (en) * 2023-09-28 2025-04-03 Color Ventures LLC Compositions and methods for alleviating pulmonary ailments

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3009598B2 (ja) * 1994-02-18 2000-02-14 武田薬品工業株式会社 プレフィルドシリンジ
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE19636150A1 (de) * 1996-09-06 1998-03-12 Asta Medica Ag N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
AU756693B2 (en) * 1997-09-29 2003-01-23 Novartis Ag Stabilized bioactive preparations and methods of use
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
WO1999066903A2 (en) 1998-06-24 1999-12-29 Advanced Inhalation Research, Inc. Large porous particles emitted from an inhaler
EP1210067A2 (en) * 1999-08-25 2002-06-05 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
NZ518401A (en) 1999-10-29 2004-01-30 Nektar Therapeutics Dry powder compositions having improved dispersivity
GB9929486D0 (en) 1999-12-15 2000-02-09 Glaxo Group Ltd Inhalation delivery apparatus and method
US20040156792A1 (en) * 2002-12-31 2004-08-12 Nektar Therapeutics Pharmaceutical formulation with an insoluble active agent
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
JP5698423B2 (ja) 2000-06-27 2015-04-08 ベクトゥラ・リミテッド 医薬組成物で使用するための粒子の製造法
US20020103139A1 (en) 2000-12-01 2002-08-01 M. Weisspapir Solid self-emulsifying controlled release drug delivery system composition for enhanced delivery of water insoluble phytosterols and other hydrophobic natural compounds for body weight and cholestrol level control
WO2003079885A2 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Inhalable sustained therapeutic formulations
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
SI1531794T1 (sl) 2002-06-28 2017-12-29 Civitas Therapeteutics, Inc. Epinefrin za vdihavanje
US20040105821A1 (en) * 2002-09-30 2004-06-03 Howard Bernstein Sustained release pharmaceutical formulation for inhalation
JP2006522634A (ja) * 2003-04-14 2006-10-05 ベクトゥラ・リミテッド 投与効率を向上させるデバイス及び製薬組成
JP2007505831A (ja) 2003-09-15 2007-03-15 ベクトゥラ・リミテッド 肺吸入による、早漏を治療するための医薬品組成物
EP1663164A2 (en) 2003-09-15 2006-06-07 Vectura Limited Methods for preparing pharmaceutical compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa

Also Published As

Publication number Publication date
HUE026045T2 (hu) 2016-05-30
SI1937229T1 (sl) 2015-08-31
PT1937229E (pt) 2015-07-16
JP2009512663A (ja) 2009-03-26
WO2007045689A3 (en) 2007-09-07
RU2008120018A (ru) 2009-11-27
ES2537777T3 (es) 2015-06-12
CY1116503T1 (el) 2017-03-15
RU2497507C2 (ru) 2013-11-10
US9138407B2 (en) 2015-09-22
EP1937229B1 (en) 2015-03-11
EP1937229A2 (en) 2008-07-02
WO2007045689A2 (en) 2007-04-26
US20080226736A1 (en) 2008-09-18
DK1937229T3 (da) 2015-06-22
JP5873616B2 (ja) 2016-03-01
PL1937229T3 (pl) 2015-08-31

Similar Documents

Publication Publication Date Title
ITMI20051999A1 (it) Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita'
ATE471144T1 (de) Intranasale verabreichung von schnell wirkendem insulin
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
IL193074A0 (en) Stable pharmaceutical formulations of montelukast sodium
DE602004027932D1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
IL231576A (en) Derivatives of adamantyl-acetamide, the pharmaceutical compositions containing them and their use in the preparation of medicines
WO2007016563A3 (en) Alcohol resistant pharmaceutical formulations
HUE040046T2 (hu) Gyógyszerészeti készítmények és hatóanyagok beadására szolgáló eljárások
IL184065A (en) Tetrahydroquinoline analogs, their use in the preparation of pharmaceuticals and pharmaceutical compositions containing them
EP2013016A4 (en) LIPOSOMAL NANOPARTICLES AND OTHER FENRETINIDE FORMULATIONS FOR THERAPY AND ACTIVE INJECTION
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
SV2009002971A (es) Enmascaramiento del sabor de polvos
EP2174972A4 (en) ALKYLENE OXIDE DERIVATIVE AND PREPARATED THEREFOR TO APPLY TO THE SKIN
IL189270A (en) Repamycins converted to phosphonate and their derivatives, pharmaceutical preparations containing them and their use in the prevention and treatment of bone and joint infections
BRPI0508170A (pt) formulações farmacêuticas para inaladores de pó seco, que compreendem um ingrediente ativo de potência de baixa dosagem
FR2873585B1 (fr) Nouvelles formulations galeniques de principes actifs
WO2005053719A3 (en) Compositions for the treatment of diseases of the oral cavity and upper respiratory tract
SE0402345D0 (sv) A metered medication dose
WO2005044186A3 (en) Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
DOP2010000138A (es) Formulaciones de polvo seco que comprenden derivados del acido ascorbico
EP2196463A4 (en) PREPARATION OF 5,6-DIMETHYLXANTHONE-4-ACETIC ACID, DERIVATIVES DERIVATED THEREOF AND PHARMACEUTICAL FORMULATIONS THEREOF
SE0200657D0 (sv) Novel Formulation
IL179021A (en) Tetrahydroisoquinoline sulfonamide derivatives, pharmaceutical compositions containing the derivative and the use thereof for the preparation of medicaments
EP1931342A4 (en) MEDIUM FOR INTRODUCTION AND MAINTENANCE OF A NARCOSE